2018
DOI: 10.1002/jpen.1166
|View full text |Cite
|
Sign up to set email alerts
|

Targeted Full Energy and Protein Delivery in Critically Ill Patients: A Pilot Randomized Controlled Trial (FEED Trial)

Abstract: A high-protein volume-based protocol with protein supplementation delivered greater amounts of protein and energy. This intervention was associated with attenuation of QMLT loss and reduced prevalence of malnutrition at ICU discharge.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
112
0
14

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 105 publications
(129 citation statements)
references
References 45 publications
2
112
0
14
Order By: Relevance
“…Six trials were eligible for inclusion, which included 511 patients ( Figure 1, PRISMA diagram). [27][28][29][30][31][32]…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Six trials were eligible for inclusion, which included 511 patients ( Figure 1, PRISMA diagram). [27][28][29][30][31][32]…”
Section: Resultsmentioning
confidence: 99%
“…The included trials were conducted over a range of years and in various regions (3 from Europe and 1 each from the United States of America, South America, and Australia) from 1993 to 2018. [27][28][29][30][31][32] The study objectives and interventions varied; however, all studies except that of Eyer et al 29 aimed to deliver protein within the guidelines' range from the outset in the intervention group and below the guidelines' range in the comparator group. In order to meet the higher protein requirements, all studies incorporated the use of a higher-protein enteral formula, with 2 studies also using supplemental protein powder.…”
Section: Study and Patient Characteristicsmentioning
confidence: 99%
“…Conversely, higher protein delivery during ICU admission has led to increased urea production and has been associated with increased muscle wasting in a small observational study [10,11,31,37]. In RCTs aiming to compare high versus lower protein delivery in critical illness, no benefit has been shown with an increased protein dose, although most have been underpowered to demonstrate an effect on clinical outcomes [11,[37][38][39]. The largest RCT (n = 474) investigating intravenous protein provided at a dose of up to 100 g/day compared to standard care found no impact on the primary outcome of renal dysfunction [37].…”
Section: Protein Delivery and Clinical Outcomesmentioning
confidence: 99%
“…Several recent trials have incorporated measures of muscle mass or physical or functional outcomes into their study design, albeit mainly as secondary outcomes or in smaller sub-studies, with varying results [10][11][12]. As an example, EAT-ICU [11] [15] and stratification by post-critical illness biology [16] as methods to refine data for outcome analyses.…”
Section: Signal-to-noise Ratiosmentioning
confidence: 99%